We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





BBI Solutions Showcases Mobile Solutions Capabilities at AACC 2019

By LabMedica International staff writers
Posted on 06 Aug 2019
BBI Solutions (Crumlin, UK) demonstrated how its lateral flow software is making point-of-care testing (POCT) more accurate, efficient and easier to use than ever before at the world’s largest laboratory medicine trade show, American Association for Clinical Chemistry (AACC) exhibition.

BBI Solutions are leading experts in immunoassay development & manufacturing services, offering an extensive portfolio of diagnostic products globally. More...
At the AACC Clinical Lab Expo, BBI’s mobile arm, Novarum, launched a demonstrator app that can read the results of an imitated malaria test. Novarum is an easy-to-use mobile app enabling rapid POCT, using just a smartphone. Novarum’s technology accurately interprets the results of lateral flow assays while offering test choreography and tracking disease outbreaks, providing clients with a competitive advantage within the diagnostic landscape. At the tradeshow, the company demonstrated how mobile technology can remove complexities from lateral flow testing to enable healthcare professionals or patients to deliver lab quality results in the field.

Novarum’s innovative mobile technology mitigates the risks identified around lateral flow by the Clinical Laboratory Improvement Amendments (CLIA), which establishes quality standards for all laboratory testing to ensure the accuracy, reliability and timeliness of patient test results. The company demonstrated every aspect of its immunoassay development - feasibility and planning, reagent supply and manufacturing, custom antibody development, custom conjugations, lateral flow development and manufacturing, as well as Novarum’s smartphone reader capability which enables immediate, POC diagnosis.

“This is an exciting opportunity to, once again, showcase BBI Solutions’ comprehensive suite of capabilities at the AACC expo. We’re particularly excited to be launching our demo app at the event this year, which enables us to demonstrate every aspect of Novarum’s capability that a potential customer could include in a custom-built app,” said John Hanson, Chief Commercial Officer at BBI Solutions. “We want to help our customers envision what it would be like for the healthcare professional or patient using the test and to highlight how Novarum’s software mitigates the risks identified around lateral flow testing.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Acute lymphoblastic leukemia in children and young people requires careful relapse risk assessment as treatment expands beyond standard chemotherapy. (Image Credit: Shutterstock)

New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL

Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more

Pathology

view channel
Image Credit: Adobe Stock

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.